Taysha Gene Therapies (TSHA)'s 30-day implied volatility (IV30) was 69.0% at the close on October 28, 2026, up from 57.4% the day before, against a 52-week range of 39.8% to 122.3%. Its 20-day historical volatility was 70.0%.
Data as of October 28, 2026.